David Carey | Lazar Partners |
Tom Looby | CEO, President and Director |
Max Scheder-Bieschin | CFO |
Matt Keeler | SunTrust Robinson Humphrey |
Greetings and welcome to the Ekso Bionics' Third Quarter 2017 Financial Results Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded.
For opening remarks, I'll now turn the call over to David Carey of Lazar Partners. Thank you, David, you may begin.